The type 1 diabetes (T1D) market across the seven major markets is projected to expand to $9.9b in 2033 from $2.2b in 2023, according to GlobalData.
Developments in biologic therapies for severe asthma, challenges remain in managing T2-low asthma, a subtype lacking typical inflammatory biomarkers.
The global endoscopic closure devices market is projected to rise by $825.7m by 2029 at a compound annual growth rate of almost 8%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback